Variant report
Variant | nsv979810 |
---|---|
Chromosome Location | chr3:21531553-21532919 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs548874657 | chr3:21531630-21531631 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs545895742 | chr3:21531650-21531651 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs504335 | chr3:21531760-21531761 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs572168823 | chr3:21531766-21531767 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs537776952 | chr3:21531815-21531816 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs185938179 | chr3:21531816-21531817 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs138451662 | chr3:21531847-21531848 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs541247207 | chr3:21531852-21531853 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs561008865 | chr3:21531879-21531880 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs534797944 | chr3:21531880-21531881 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs61228100 | chr3:21531890-21531891 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs6793355 | chr3:21531908-21531909 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs530054334 | chr3:21531909-21531910 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs574695880 | chr3:21531961-21531962 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs541840873 | chr3:21531970-21531971 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs148865882 | chr3:21531972-21531973 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs575912822 | chr3:21531982-21531983 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs143558691 | chr3:21532044-21532045 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs564924774 | chr3:21532059-21532060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs138101267 | chr3:21532077-21532078 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs532348324 | chr3:21532135-21532136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs547133323 | chr3:21532173-21532174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs538756720 | chr3:21532176-21532177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs372717115 | chr3:21532219-21532220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs375984136 | chr3:21532238-21532239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs11707385 | chr3:21532243-21532244 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs3965317 | chr3:21532264-21532265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs569698874 | chr3:21532298-21532299 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs537738179 | chr3:21532299-21532300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs563274508 | chr3:21532321-21532322 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs373709657 | chr3:21532338-21532339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs367759815 | chr3:21532378-21532379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs570915144 | chr3:21532475-21532476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs535222621 | chr3:21532479-21532480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs553162771 | chr3:21532481-21532482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs574605331 | chr3:21532646-21532647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs5847104 | chr3:21532708-21532709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs397789133 | chr3:21532717-21532718 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs62235557 | chr3:21532720-21532721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs138812078 | chr3:21532822-21532823 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs532202658 | chr3:21532823-21532824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs575279222 | chr3:21532858-21532859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs141960494 | chr3:21532918-21532919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Breast cancer | 17133270 | CNVD |
Developmental delay | 21147756 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 20688739 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:21515800-21563000 | Weak transcription | Fetal Stomach | stomach |
2 | chr3:21519800-21549000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr3:21524000-21537000 | Weak transcription | Fetal Muscle Leg | muscle |
4 | chr3:21526200-21559000 | Weak transcription | Aorta | Aorta |
5 | chr3:21529400-21531600 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
6 | chr3:21531600-21532000 | Enhancers | Pancreatic Islets | Pancreatic Islet |